ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,997Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 1006

$636K Total Retail Price of All Prescriptions

Rank: 134 out of 1006

384 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 384 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 384 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 5,988 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 410 222 1 3
AMLODIPINE BESYLATE 365 273 2 4
SIMVASTATIN 341 198 3 1
LEVOTHYROXINE SODIUM 318 169 4 2
ATORVASTATIN CALCIUM 290 189 5 5
METFORMIN HCL 245 125 6 10
CRESTOR 214 136 7 18
ZOLPIDEM TARTRATE 211 131 8 14
HYDROCHLOROTHIAZIDE 208 125 9 11
METOPROLOL SUCCINATE 185 131 10 12
TRAMADOL HCL 179 130 11 35
FUROSEMIDE 178 126 12 6
PANTOPRAZOLE SODIUM 171 104 13 32
NEXIUM 152 93 14 28
OMEPRAZOLE 143 104 15 9
AZITHROMYCIN 135 69 16 39
HYDROCODONE-ACETAMINOPHEN 130 70 S3 17 25
LANTUS SOLOSTAR 121 71 18 93
LOVAZA 116 69 19 157
METOPROLOL TARTRATE 115 71 20 7
GABAPENTIN 107 78 21 20
GLYBURIDE 107 89 R 21 65
JANUVIA 102 81 23 49
NASONEX 93 53 24 176
ZETIA 91 42 25 51
PROAIR HFA 90 46 26 64
PRAVASTATIN SODIUM 88 76 27 15
ESCITALOPRAM OXALATE 88 53 27 27
CLOPIDOGREL 88 57 27 46
CITALOPRAM HBR 86 35 30 24
SYMBICORT 86 65 30 147
DEXILANT 86 46 30 142
IBUPROFEN 84 25 33 114
DONEPEZIL HCL 77 74 34 17
WARFARIN SODIUM 77 52 34 8
ATENOLOL 74 45 36 13
LIPITOR 73 49 37 47
ALENDRONATE SODIUM 72 57 38 29
POTASSIUM CHLORIDE 70 55 39 30
TRAZODONE HCL 69 44 40 21
SINGULAIR 69 35 40 82
LOSARTAN POTASSIUM 65 33 42 22
OXYCODONE-ACETAMINOPHEN 65 20 S2 42 57
CLOTRIMAZOLE-BETAMETHASONE 62 43 44 111
RAMIPRIL 61 60 45 79
ENALAPRIL MALEATE 60 35 46 83
PLAVIX 59 42 47 61
CARVEDILOL 57 55 48 36
NYSTATIN 56 44 49 191
LYRICA 56 15 49 115
SERTRALINE HCL 55 37 51 19
GLYBURIDE MICRONIZED 55 33 R 51 363
SPIRIVA 54 40 53 48
SYNTHROID 53 34 54 42
MELOXICAM 53 11 54 67
LANTUS 52 24 56 43
DIVALPROEX SODIUM ER 51 0 57 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.